AlzeCure Pharma
AlzeCure Pharma to present at Redeye Theme: Alzheimer & Parkinsons on April 8
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company is participating at Redeye Theme: Alzheimer & Parkinsons on April 8, 10:55am, when CEO Martin Jönsson presents the company and its pipeline within Alzheimer’s.
Watch the livestream via https://www.redeye.se/events/1052619/redeye-theme-alzheimer-parkinsons
The session will also be available afterwards on AlzeCure's company page at Redeye www.redeye.se/company/alzecure-pharma, and on AlzeCure's website www.alzecurepharma.se/en/presentations-and-interviews/.
Time: 10.30am – 12.00pm CET, April 8
Venue: Redeye, Mäster Samuelsgatan 42, Stockholm, Sweden
Datum | 2025-04-01, kl 10:00 |
Källa | MFN |
AlzeCure Pharma to present at Redeye Theme: Alzheimer & Parkinsons on April 8 | |
Martin Jönsson CEO AlzeCure Pharma |
